Aquaporin-9 downregulation prevents steatosis in oleic acid-induced non-alcoholic fatty liver disease cell models
Authors:
- Zi-Lan LvZLZi-Lan Lv
- Yu-Jun KangYKYu-Jun Kang
- Ting-Xiu XiangTXTing-Xiu Xiang
- Pi-Long WangPWPi-Long Wang
- Zheng JiangZJZheng Jiang
- 19 September 2013
- journal article
- Published by Spandidos Publications in International Journal of Molecular Medicine
- Vol. 32 (5) , 1159-1165
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 30 references indexed in Scilit:
- Physical activity: an essential component of lifestyle modification in NAFLDNature Reviews Gastroenterology & Hepatology, 2012
- Implications of aquaglyceroporins 7 and 9 in glycerol metabolism and metabolic syndromeMolecular Aspects of Medicine, 2012
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological AssociationHepatology, 2012
- Nonalcoholic fatty liver diseaseBest Practice & Research Clinical Gastroenterology, 2010
- Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic, and Clinical ImplicationsHepatology, 2010
- Metabolic impact of adipose and hepatic glycerol channels aquaporin 7 and aquaporin 9Nature Clinical Practice Endocrinology & Metabolism, 2008
- Aquaporins and Fetal Fluid BalancePlacenta, 2008
- Function of aquaporins in female and male reproductive systemsHuman Reproduction Update, 2006
- Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of EthnicityHepatology, 2004
- Immunolocalization of AQP9 in Liver, Epididymis, Testis, Spleen, and BrainBiochemical and Biophysical Research Communications, 2000